glp-1 molecule Drugs and the Physiology of Metabolic Health GLP-1: Molecular mechanisms and outcomes

Theres no denying that this drug class can lead to significant health benefits, particularly for those with type 2 diabetes and/or obesity

In SURMOUNT-1, tirzepatide at 15 mg weekly produced 22.5% average weight loss over 72 weeks

15.2.10 STRUCTURE THERAPEUTICS, INC

Research consistently shows that people who prioritize protein on GLP-1 medications lose more fat and less muscle than those who do not

Type 2 diabetes with cardiovascular risk Injectable semaglutide has direct cardiovascular outcome data in patients with established cardiovascular disease and overweight or obesity, from the SELECT trial

According to FDA prescribing information, a slower dose escalation schedule may reduce gastrointestinal symptoms